Find a Clinical Trial

Find a Clinical Trial

Use the abbreviation for your state (ie. FL, TX, NV)
Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Florida Cancer Affiliates - Ocala

A PHASE 3B RANDOMIZED STUDY OF LENALIDOMIDE (CC-5013) PLUS RITUXIMAB MAINTENANCE THERAPY FOLLOWED BY LENALIDOMIDE SINGLE-AGENT MAINTENANCE VERSUS RITUXIMAB MAINTENANCE IN SUBJECTS WITH RELAPSED/REFRACTORY FOLLICULAR, MARGINAL ZONE OR MANTLE CELL LYMPHOMA (CC-5013-NHL-008)(MAGNIFY)

  • Details

ClinicalTrials.gov ID: NCT01996865
Diagnosis Type: Non-Hodgkins
USOR Number: 13064

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Lung Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

CA209-817: A Phase IIIb/IV Safety and Efficacy Trial of Flat Dose Nivolumab in Combination with Ipilimumab in Participants with Non-Small Cell Lung Cancer

  • Details

ClinicalTrials.gov ID: NCT02869789
Diagnosis Type: NSCLC
USOR Number: 16156

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Lung Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

CA209370: A Master Protocol of Phase 1/2 Studies of Nivolumab in Advanced NSCLC Using Nivolumab as Maintenance after Induction Chemotherapy or as First-line Treatment Alone or in Combination with Standard of Care Therapies

  • Details

ClinicalTrials.gov ID: NCT02574078
Diagnosis Type: NSCLC
USOR Number: 14158

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Neuroendocrine Tumors

Clinical Trial at: Florida Cancer Affiliates - Ocala

A Phase 3, Prospective, Randomized, Double-Blind, Multi-Center, Study of the Efficacy and Safety of Lanreotide Autogel/ Depot 120 mg plus BSC vs. Placebo plus BSC for Tumour Control in Subjects with Well Differentiated, Metastatic and/or Unresectable Typical or Atypical Lung Neuroendocrine Tumours (Spinet) - Ipsen A-US-52030-328

  • Details

ClinicalTrials.gov ID: NCT02683941
Diagnosis Type: NA
USOR Number: 15079

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Mesothelioma

Clinical Trial at: Florida Cancer Affiliates - Ocala

Double blind, randomised, multicentre, phase II/III study of nintedanib in combination with pemetrexed/cisplatin followed by continuing nintedanib monotherapy versus placebo in combination with pemetrexed/cisplatin followed by continuing placebo monotherapy for the treatment of patients with unresectable malignant pleural mesothelioma (1199.93)

  • Details

ClinicalTrials.gov ID: NCT01907100
Diagnosis Type: NA
USOR Number: 15175

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Lung Cancer

Clinical Trial at: Florida Cancer Affiliates - Ocala

A Dose Frequency Optimization, Phase IIIB/IV Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects with Advanced or Metastatic Non-small Cell Lung Cancer who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks(CheckMate 384- CA209384)

  • Details

ClinicalTrials.gov ID: NCT02713867
Diagnosis Type: NA
USOR Number: 15203

  • Practice Details

433 SW 10th Street
Ocala, Florida 34471
111.28 mi. away
P: (352) 732-4032

More Details View Practice Page

Pages